Cardiopulmonary Exercise Testing Market Research Report - Forecast till 2030

Cardiopulmonary Exercise Testing Market: Information by Product (Cardiopulmonary Exercise Testing (CPET) Systems, Single-Photon Emission Computed Tomography (SPECT), Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors and others), by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East Africa) - Forecast till 2030

ID: MRFR/HC/5163-CR | 157 Pages | Published By Rahul Gotadki on July 2019         

1 Report Prologue

2 Introduction

2.1 Definition 14

2.2 Scope of the Study 14

2.3 Research Objective 14

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.4.3 Market Structure 15

3 Research Methodology

3.1 Primary Research Methodology 17

3.2 Secondary Research Methodology 18

3.3 Market Size Estimation 19

3.4 Forecast Model 19

4 Market Dynamics

4.1 Introduction 22

4.2 Drivers 23

4.2.1 Rising Geriatric Population 23

4.2.2 Rising Cardiovascular Diseases 23

4.2.3 Research and Development 23

4.3 Restraints 24

4.3.1 High Cost 24

4.3.2 Regulatory Affairs 24

4.4 Opportunity 24

4.4.1 Entering Developing Markets 24

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 26

5.1.1 Bargaining Power of Suppliers 26

5.1.2 Bargaining Power of Buyers 26

5.1.3 Threat of New Entrants 26

5.1.4 Threat of Substitutes 27

5.1.5 Intensity of Rivalry 27

5.2 Price Analysis 27

5.3 Investment Opportunity Analysis 27

5.4 Value Chain Analysis 28

5.4.1 Supporting Activity 28

5.4.2 Inbound Logistics 28

5.4.3 Operations 28

5.4.4 Marketing and Sales 28

5.4.5 Outbound Logistics 28

5.4.6 Customer Services 29

6 Cardiopulmonary Exercise Testing Market, by Product

6.1 Introduction 31

6.2 Cardiopulmonary Exercise Testing (CPET) Systems 33

6.3 Single-Photon Emission Computed Tomography (SPECT) 34

6.4 Echocardiogram 34

6.5 Pulse Oximeters 35

6.6 Stress Blood Pressure Monitors 35

7 Cardiopulmonary Exercise Testing Market, by End-User

7.1 Introduction 37

7.2 Hospitals and Clinics 38

7.3 Diagnostic Centers 38

7.4 Ambulatory Centers 39

7.5 Others 39

8 Global Cardiopulmonary Exercise Testing Market, by Region

8.1 Introduction 41

8.2 Americas 42

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.2.1 North America 44

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.2.1.1 US. 46

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.2.1.2 Canada 47

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.2.2 South America 48

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3 Europe 49

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1 Western Europe 51

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.1 Germany 53

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.2 France 54

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.3 UK 55

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.4 Italy 56

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.5 Spain 57

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.1.6 Rest of Western Europe 58

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.3.2 Eastern Europe 59

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4 Asia-Pacific 60

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.1 Japan 62

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.2 China 63

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.3 India 64

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.4 Australia 65

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.5 South Korea 66

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.4.6 Rest of Asia-Pacific 67

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.5 Middle East and Africa 68

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.5.1 Middle East 70

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

8.5.2 Africa 71

Cardiopulmonary Exercise Testing Market, by Product

Cardiopulmonary Exercise Testing Market, by End-User

9 Company Landscape

9.1 Company Share Analysis 73

10 Company Profiles

10.1 Cardinal Health 75

10.1.1 Company Overview 75

10.1.2 Financial Overview 75

10.1.3 Products Offering 76

10.1.4 Key Developments 76

10.1.5 SWOT Analysis 76

10.1.6 Key Strategy 76

10.2 COSMED SRL 77

10.2.1 Company Overview 77

10.2.2 Financial Overview 77

10.2.3 Products Offering 77

10.2.4 Key Developments 77

10.2.5 SWOT Analysis 78

10.2.6 Key Strategy 78

10.3 GE Healthcare 79

10.3.1 Company Overview 79

10.3.2 Financial Overview (Healthcare Segment) 79

10.3.3 Products Offering 80

10.3.4 Key Developments 80

10.3.5 SWOT Analysis 80

10.3.6 Key Strategy 81

10.4 Halma PLC 82

10.4.1 Company Overview 82

10.4.2 Financial Overview 82

10.4.3 Products Offering 83

10.4.4 Key Developments 83

10.4.5 SWOT Analysis 83

10.4.6 Key Strategy 83

10.5 Hill-Rom Holdings, Inc. 84

10.5.1 Company Overview 84

10.5.2 Financial Overview 84

10.5.3 Products Offering 85

10.5.4 Key Developments 85

10.5.5 SWOT Analysis 85

10.5.6 Key Strategy 85

10.6 Koninklijke Philips NV. 86

10.6.1 Company Overview 86

10.6.2 Financial Overview 86

10.6.3 Products Offering 87

10.6.4 Key Developments 88

10.6.5 SWOT Analysis 88

10.6.6 Key Strategy 88

10.7 MGC Diagnostics Corporation 89

10.7.1 Company Overview 89

10.7.2 Financial Overview 89

10.7.3 Products Offering 89

10.7.4 Key Developments 89

10.7.5 SWOT Analysis 90

10.7.6 Key Strategy 90

10.8 NIHON KOHDEN CORPORATION 91

10.8.1 Company Overview 91

10.8.2 Financial Overview 91

10.8.3 Products Offering 92

10.8.4 Key Developments 92

10.8.5 SWOT Analysis 92

10.8.6 Key Strategy 92

10.9 Schiller AG 93

10.9.1 Company Overview 93

10.9.2 Financial Overview 93

10.9.3 Products Offering 93

10.9.4 Key Developments 94

10.9.5 SWOT Analysis 94

10.9.6 Key Strategy 94

10.10 Masimo Corporation 95

10.10.1 Company Overview 95

10.10.2 Financial Overview 95

10.10.3 Products Offering 96

10.10.4 Key Developments 96

10.10.5 SWOT Analysis 96

10.10.6 Key Strategy 97

10.11 Vyaire Medical, Inc. 98

10.11.1 Company Overview 98

10.11.2 Financial Overview 98

10.11.3 Products Offering 98

10.11.4 Key Developments 98

10.11.5 SWOT Analysis 99

10.11.6 Key Strategy 99

11 Appendix

11.1 Discussion Blue Print 101

11.2 References 102

12 List of Tables

TABLE 1 PRIMARY INTERVIEWS 18

TABLE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 31

TABLE 3 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR CARDIOPULMONARY EXERCISE TESTING (CPET) SYSTEMS,

BY REGION, 2020–2027 (USD MILLION) 32

TABLE 4 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR SINGLE–PHOTON EMISSION COMPUTED

TOMOGRAPHY (SPECT), BY REGION, 2020–2027 (USD MILLION) 33

TABLE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR ECHOCARDIOGRAM, BY REGION, 2020–2027 (USD MILLION) 33

TABLE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR PULSE OXIMETERS, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR STRESS BLOOD PRESSURE MONITORS, BY REGION,

2020–2027 (USD MILLION) 34

TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 36

TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION,

2020–2027 (USD MILLION) 37

TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR DIAGNOSTIC CENTERS, BY REGION,

2020–2027 (USD MILLION) 37

TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR AMBULATORY CENTERS, BY REGION,

2020–2027 (USD MILLION) 38

TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 40

TABLE 13 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 41

TABLE 14 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 42

TABLE 15 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 42

TABLE 16 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 43

TABLE 17 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 44

TABLE 18 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 44

TABLE 19 US CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 45

TABLE 20 US CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 45

TABLE 21 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 46

TABLE 22 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 46

TABLE 23 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 47

TABLE 24 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 47

TABLE 25 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 48

TABLE 26 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 49

TABLE 27 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 49

TABLE 28 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 50

TABLE 29 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 51

TABLE 30 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 51

TABLE 31 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 52

TABLE 32 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 52

TABLE 33 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 53

TABLE 34 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 53

TABLE 35 UK CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 54

TABLE 36 UK CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 54

TABLE 37 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 55

TABLE 38 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 55

TABLE 39 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 56

TABLE 40 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 56

TABLE 41 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 57

TABLE 42 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 57

TABLE 43 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 58

TABLE 44 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 58

TABLE 45 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 59

TABLE 46 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 60

TABLE 47 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 60

TABLE 48 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 61

TABLE 49 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 61

TABLE 50 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 62

TABLE 51 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 62

TABLE 52 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 63

TABLE 53 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 63

TABLE 54 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 64

TABLE 55 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 64

TABLE 56 SOUTH KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 65

TABLE 57 SOUTH KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 65

TABLE 58 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 66

TABLE 59 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 66

TABLE 60 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 67

TABLE 61 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 68

TABLE 62 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 68

TABLE 63 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 69

TABLE 64 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 69

TABLE 65 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 70

TABLE 66 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 70

13 List of Figures

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 19

FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET 21

FIGURE 3 PORTER’S FIVE FORCES MODEL 25

FIGURE 4 VALUE CHAIN: CARDIOPULMONARY EXERCISE TESTING MARKET 27

FIGURE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 30

FIGURE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2020 & 2027 (USD MILLION) 36

FIGURE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 & 2027 (USD MILLION) 40

FIGURE 8 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 41

FIGURE 9 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020 (%) 43

FIGURE 10 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 48

FIGURE 11 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020 (%) 50

FIGURE 12 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020(%) 59

FIGURE 13 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 67

FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET COMPANY SHARE ANALYSIS, 2020 (%) 72